Entera Appoints Global BioPharma Executive Laura Hamill to Its Board of Directors, Expanding Commercial Expertise
Go back to Entera Appoints Global BioPharma Executive Laura Hamill to Its Board of Directors, Expanding Commercial Expertise| Entrx Corporation (NASDAQ: ENTX) | Delayed: 3.05 +0.03 (0.99%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.02 | 52 Week High | $0.30 | |||
| Open | $3.12 | 52 Week Low | $0.10 | |||
| Day High | $3.20 | P/E | N/A | |||
| Day Low | $2.96 | EPS | $0.00 | |||
| Volume | 784,598 | |||||
| FATE THERAPEUTICS (NASDAQ: FATE) | Delayed: 2.07 +0.01 (0.49%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.06 | 52 Week High | $4.76 | |||
| Open | $2.06 | 52 Week Low | $1.46 | |||
| Day High | $2.14 | P/E | N/A | |||
| Day Low | $2.05 | EPS | $-1.91 | |||
| Volume | 1,215,102 | |||||
| JAZZ PHARMACEUTICAL (NASDAQ: JAZZ) | Delayed: 211.97 -1.79 (0.84%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $213.76 | 52 Week High | $160.00 | |||
| Open | $213.75 | 52 Week Low | $95.80 | |||
| Day High | $215.13 | P/E | 39.40 | |||
| Day Low | $211.53 | EPS | $5.38 | |||
| Volume | 695,908 | |||||



